Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Immune Disease Start-Up Raises $28M in Early Funds

A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing. . . . → Read More: Immune Disease Start-Up Raises $28M in Early Funds

Exosuit Prototype Unveiled for Stroke Survivors

An assistive device with sensors and motors designed to help people with stroke and other muscle disorders walk more normally was demonstrated on 16 June. . . . → Read More: Exosuit Prototype Unveiled for Stroke Survivors

Engineered Immune Cells to be Explored for Solid Tumors

A cancer research center and biotechnology company will examine genetically engineered immune system cells as possible treatments for solid tumor cancers. . . . → Read More: Engineered Immune Cells to be Explored for Solid Tumors

Univ. Spin-Off Discovering New Antibiotics

A new enterprise founded by three microbiologists at Harvard Medical School is licensing the founders’ research to find treatments for antibiotic-resistant bacteria. . . . → Read More: Univ. Spin-Off Discovering New Antibiotics

Personalized Drug Delivery System Demonstrated

Biomedical engineers developed and demonstrated in lab animals a closed-loop system that monitors and controls delivery of drugs to meet an individual’s personalized needs. . . . → Read More: Personalized Drug Delivery System Demonstrated

Univ. Spin-Off Creating Baby Brain Development Food

A start-up enterprise spun-off from the Duke-NUS medical school in Singapore is licensing research for a new food product for mothers to help a baby’s cognitive development. . . . → Read More: Univ. Spin-Off Creating Baby Brain Development Food

$2 Billion Biotech Licensing Deal Cancelled

A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday. . . . → Read More: $2 Billion Biotech Licensing Deal Cancelled

Gene Therapy Start-Up Raises $41M in Early Funds

A 1 year-old enterprise developing gene therapies to treat rare inherited metabolic disorders is raising €37.5 million ($US 40.8 million) in its first venture funding round. . . . → Read More: Gene Therapy Start-Up Raises $41M in Early Funds

Shire Licensing Dry Eye Disease Treatment in $535M Deal

An experimental drug for treating dry eye disease, a common disorder affecting older individuals, is being licensed by international pharmaceutical company Shire plc. . . . → Read More: Shire Licensing Dry Eye Disease Treatment in $535M Deal

NIH Funds Drug-Resistant Malaria Therapy Trial

An agency of National Institutes of Health is funding a clinical trial of a new malaria drug engineered to overcome resistance developed to earlier treatments. . . . → Read More: NIH Funds Drug-Resistant Malaria Therapy Trial